Given The point that you can see less rating outcomes over the fold on cell, folks have assumed that the CTR would be larger for the 1st benefits on cell products. Let's have a look at if that's the scenario: I'd guess https://markets.businessinsider.com/news/stocks/linkdaddy-announces-ctr-manipulation-google-visibility-lead-generation-service-1032758570